|
|
|
|
Office Locations:
|
425 Walnut Street, Suite 1800
Cincinnati, OH 45202
| | |
|
|
|
|
Electronics & Advanced Materials
Information Technology
Life Sciences & Healthcare
Software & Internet
|
|
|
Narya is a thesis-driven, early-stage venture capital firm that invests long term capital in people who use technology to solve significant challenges. The firm plans to raise a total of $125 million, which will be used to invest in tech startups in under-served cities such as Salt Lake City, Atlanta and Raleigh-Durham. Narya will focus on companies within life sciences, aerospace and defense and robotics, as well as commercializing technologies developed at research institutions, and will make investments in the range of $5 million to $10 million. J.D. Vance, founder of Narya, is the bestselling author of Hillbilly Elegy and named the firm after one of the rings in J.R.R. Tolkien's The Lord of the Rings.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
| Name | |
| |
Title | |
Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
|
| Colin Greenspon | |
| |
Co-Founding Partner | |
| Falon Donohue | |
| |
Partner | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
05/27/2026
|
Reprogram Biosciences
|
CA
|
$6,000,000
|
Seed
|
04/28/2026
|
True Anomaly
|
CO
|
$650,000,000
|
Series D
|
04/09/2026
|
Chapter
|
NY
|
$100,000,000
|
Series E
|
01/08/2026
|
Valinor Enterprises
|
DC
|
$54,000,000
|
Series A
|
10/16/2025
|
Peptilogics
|
PA
|
$78,000,000
|
Series B-2
|
|
|
|
|
|
|
|
